| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $215.0K | $445.4K | $744.0K |
| YoY Revenue Growth % | -51.7% | -40.1% | — |
| Gross Profit | -$2.4M | -$912.7K | — |
| Gross Margin % | -50.0% | -50.0% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$21.1M | -$12.8M | -$8.6M |
| Operating Margin % | -80.0% | -80.0% | -80.0% |
| Net Income (GAAP) | -$21.0M | -$12.4M | -$8.1M |
| EBITDA (Normalized) | -$19.6M | -$12.4M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$14.3M | -$10.6M | -$9.0M |
| Capital Expenditures (CapEx) | $1.9M | $554.9K | — |
| Free Cash Flow (FCF) | -$16.2M | -$11.1M | -$9.0M |
| FCF Margin % | -80.0% | -80.0% | -80.0% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | — | $10.7M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $6.7M | $15.5M | — |